Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
- Status
- WITHDRAWN
- Phase
- NA
Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
- Status
- COMPLETED
- Phase
- N/A
A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Fulvestrant + Neratinib In Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
- Status
- WITHDRAWN
- Phase
- N/A
A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
- Status
- COMPLETED
- Phase
- PHASE1
Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.
- Status
- TERMINATED
- Phase
- PHASE2
Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey
- Status
- COMPLETED
- Phase
- N/A
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE3
A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2